DEXLANSOPRAZOLE PEDIATRIC clinical trials

A Phase 2, Double-Blind, 36-Week, Multicenter Study to Assess the Safety and Effectiveness of Daily Oral Administration of Dexlansoprazole Delayed-Release Capsules for Healing of Erosive Esophagitis (EE) and Maintenance of Healed EE in Pediatric Subjects Aged 2 to 11 Years With EE

This study is looking at a medicine called dexlansoprazole for children aged 2 to 11 with 'erosive oesophagitis' (a sore gullet). It wants to see if the medicine helps heal the gullet and keep it healed, and if it's safe.